background preloader

Prescriptions

Facebook Twitter

Is Insulin the New EpiPen? Families Facing Sticker Shock Over 400 Percent Price Hike. Is insulin is the new EpiPen?

Is Insulin the New EpiPen? Families Facing Sticker Shock Over 400 Percent Price Hike

In the last eight years, the average price per milliliter of insulin has skyrocketed by over 200 percent. Prescription Prices, Coupons & Pharmacy Information - GoodRx. 4 commonly prescribed drugs that may be more dangerous than Big Pharma is telling you. This article originally appeared on AlterNet.

4 commonly prescribed drugs that may be more dangerous than Big Pharma is telling you

They are so common no one thinks twice about them: drug ads that tell you about a disease you might have, a pill that could treat it, and tell you to “ask your doctor” if the pill is right for you. Until 1997, such direct-to-consumer ads did not exist because without a doctor’s recommendation, how could people know if the medication was appropriate or safe? The only thing people knew about drugs and drug risks was from ads they peeked at in medical journals at the doctor’s office.

Big Pharma Lobbyists Trying To Stop Drug Price Relief Act In Ohio. Caution! These 10 Drugs Can Cause Memory Loss - Life Reimagined. For a long time doctors dismissed forgetfulness and mental confusion as a normal part of aging.

Caution! These 10 Drugs Can Cause Memory Loss - Life Reimagined

But scientists now know that memory loss as you get older is by no means inevitable. Indeed, the brain can grow new brain cells and reshape their connections throughout life. Most people are familiar with at least some of the things that can impair memory, including alcohol and drug abuse, heavy cigarette smoking, head injuries, stroke, sleep deprivation, severe stress, vitamin B12 deficiency, and illnesses such as Alzheimer's disease and depression. But what many people don't realize is that many commonly prescribed drugs also can interfere with memory. Pharmaceutical corporations rake in billions on pneumonia vaccines while millions in poor countries go without. Martin Shkreli: Of Rotten Apples and Rotten Systems. Martin Shkreli, the former hedge-fund manager turned pharmaceutical CEO who was arrested last week, has been described as a sociopath and worse.

Martin Shkreli: Of Rotten Apples and Rotten Systems

In reality, he’s a brasher and larger version of what others in finance and corporate suites do all the time. Federal prosecutors are charging him with conning wealthy investors. Lying to investors is illegal, of course, but it’s perfectly normal to use hype to lure rich investors into hedge funds. Turing Pharma CEO Martin Shkreli arrested - Reuters witness - AOL. NEW YORK, Dec 17 (Reuters) - Martin Shkreli, a lightning rod for growing outrage over soaring prescription drug prices, was arrested by the FBI on Thursday after a federal investigation involving his former hedge fund and a pharmaceutical company he previously headed.

Turing Pharma CEO Martin Shkreli arrested - Reuters witness - AOL

The securities fraud probe of Shkreli, who is now chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc, stems from his time as manager of hedge fund MSMB Capital Management and CEO of biopharmaceutical company Retrophin Inc, a person familiar with the matter said. Shares of KaloBios fell about 50 percent in premarket trading. Lawyers for Retrophin and Shkreli, whose arrest was witnessed by Reuters, did not immediately respond to a request for comment.

Swallow Pills More Easily With Special Cups and Techniques. Martin Shkreli walks back on pledge to lower price of HIV drug Daraprim. Human Rights Campaign. Today, HRC issued the following statement after Ben Carson was asked in the debate last night and refused to say they would take action against companies like Turing Pharmaceuticals for outrageous and fundamentally unacceptable price increases.

Human Rights Campaign

Turing’s CEO Martin Shkreli is infamous for recently raising the price of Daraprim -- a crucial and often lifesaving treatment by 5,000 percent. “It’s shocking and bad enough that the greedy price gouging from Turing is jeopardizing the health of women, children, infants, and people living with HIV,” said JoDee Winterhof, Senior Vice President of Policy and Political Affairs for the Human Rights Campaign. Pharma CEO "Only Cares About Shareholders" Loses Their Money. Following a trail blazed by notorious Turing Pharmaceuticals CEO Martin Shkreli, Valeant Pharmaceutical CEO J.

Pharma CEO "Only Cares About Shareholders" Loses Their Money

Don’t feed the Shkreli: The Turing Pharma CEO’s pathetic Twitter antics are about as funny as his price-gouging. The Guy Who Raised the Cost of the AIDS Drug Isn’t the Problem. Support more videos like this at patreon.com/rebecca!

The Guy Who Raised the Cost of the AIDS Drug Isn’t the Problem

Sorta transcript: Martin Shkrelli is a hedge fund manager who has recently come under fire for being the world’s biggest piece of shit after it was revealed he raised the price of the drug Daraprim from $13.50 to $750 per pill. Daraprim is used by both pregnant women and AIDS patients to literally save their lives. Label cuts ties with hedge fund man who boosted Aids drug price 5,000% The Family that became Billionaires Thanks to other People’s Pain. The newest addition to Forbes’ list of the richest American families is the Sacklers, who made billions of dollars off the suffering of others.

The Family that became Billionaires Thanks to other People’s Pain

The Sacklers own Purdue Pharma, maker of Oxycontin, a heavy-duty painkiller that has turned millions into addicts. Sales of the drug have been tremendous for the Sacklers. The family’s worth is estimated to be $14 billion, making them the 16th richest family in the country, according to Forbes. Purdue has made $35 billion from Oxy sales since the company introduced it in the mid-1990s under the company founders, brothers Mortimer and Raymond Sackler. Oxycontin had been around since World War I and was originally reserved for cancer patients because of its potency and addictive properties. PROOF! Glaxo Pharmaceuticals Deliberately LIED About Teen Suicide Risk. Paroxetine is an antidepressant that was reported as both safe and effective for use in adolescence, but the notes from the clinical trial tell a different story.

PROOF! Glaxo Pharmaceuticals Deliberately LIED About Teen Suicide Risk

Hope for a real report on the drug’s effects came in the form of Professor Jon Jureidini of the University of Adelaide. Jueridini is disputing the claims made by Study 329, again the study performed by a drug corporation, in the British Medical Journal. He had this to say about the study: “Although concerns had already been raised about Study 329, and the way it was reported, the data was not previously made available so researchers and clinicians weren’t able to identify all of the errors in the published report. It wasn’t until the data was made available for re-examination that it became apparent that paroxetine was linked to serious adverse reactions, with 11 of the patients taking paroxetine engaging in suicidal or self-harming behaviors compared to only one person in the group of patients who took the placebo.”

Drug Corporation Buys AIDS And Cancer Medication, Hikes Up Price By 5000% In a disturbing tale that exemplifies the fact that corporations do not act in the best interest of the people, a drug corporation has bought the rights to an AIDS and cancer medication and hiked the price up by 5000%. Daraprim is a drug designed to treat cancer and AIDS by fighting Toxoplasmosis, a common food-borne illness that easily affects people with immune systems affected by AIDS or chemotherapy. The rights to Deraprim had been controlled by Impax Laboratories until they were recently purchased by Turing Pharmaceuticals of New York. Shortly after Turing Pharmaceuticals of New York purchased the rights to Daraprim, they increased the price of the drug from $13.50 per pill to $750 per pill. What You Need To Know About Congress' Effort To Speed Up Drug Approval. The House recently passed the 21st Century Cures Act (H.R. 6) by an overwhelming 344-77 vote.

This legislation — which aims to improve the Food and Drug Administration’s drug and medical device development system and spur the creation of treatments for thousands of conditions — has support among a bipartisan coalition of lawmakers, pharmaceutical companies, patient advocacy groups, and medical organizations. Still, some detractors have expressed concern about Big Pharma’s growing influence and the potential of deadly mistakes. Here’s what you need to know about what’s in the bill and where advocates stand: What would the 21st Century Cures Act do? Under the 21st Century Cures Act, the Food and Drug Administration would be able to directly incorporate the experiences of patients with certain disorders and their reactions to new therapies in a manner that protects privacy.

The House Committee on Energy and Commerce says the 21st Century Cures Act will reduce the deficit by $500 million. This Hepatitis C Drug, Developed with U.S. Government-Funded Research, Costs $300 per Treatment Course in India…and $84,000 in the U.S. A breakthrough in treating hepatitis C costs almost 300 times more in the United States than it does in India, a disparity made all the more outrageous by the fact that the U.S. government helped fund the research responsible for the drug. CVS Health Accused in Suit of Overcharging for Generic Drugs. CVS Health Corp. was accused in a lawsuit by pharmacy customers of intentionally overcharging for generic prescription drugs by submitting claims for payment to third parties at inflated prices.

Beginning in 2008, CVS orchestrated a “massive fraud that resulted in substantial ill-gotten gains,” according to the complaint filed Thursday in San Francisco federal court. The Rise of Big Generic: Why Knockoff Prescriptions Now Cost $1,200. Generic Medicines Used to be Cheap…Not Any More. This Hepatitis C Drug, Developed with U.S. Government-Funded Research, Costs $300 per Treatment Course in India…and $84,000 in the U.S.

Doctors Protest Big Pharma's Out of Control Greed Which is Bankrupting Ill Patients. Photo Credit: Image by Shutterstock, Copyright (c) Brian A. This Hepatitis C Drug, Developed with U.S. Government-Funded Research, Costs $300 per Treatment Course in India…and $84,000 in the U.S. Glogin?mobile=1&URI= Big Pharma Has An Interest in Rich People Being Sick. Photo Credit: Pixelbliss/Shutterstock.com. Quitting Ambien Risks. Rx Outreach. Generic Drugs Up 1,000% By Sam P.K. Collins Posted on. Patient Assistance Program, Discount Prescription Drugs. RxRelief Card. Needy Meds. Ohio's Best Rx. Partnership for Prescription Assistance.

RxforOhio.